Heterogeneity in Breast Cancer and the Problem of Relevance of Findings

por Aubele, M., Werner, M.
Publicado 1999

Increasing chromosome 1 copy number parallels histological progression in breast carcinogenesis

por Cummings, M C, Aubele, M, Mattis, A, Purdie, D, Hutzler, P, Höfler, H, Werner, M
Publicado 2000

Chromosomal changes during development and progression of prostate adenocarcinomas

por Zitzelsberger, H, Engert, D, Walch, A, Kulka, U, Aubele, M, Höfler, H, Bauchinger, M, Werner, M
Publicado 2001

PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas

por Aubele, M, Auer, G, Walch, A K, Munro, A, Atkinson, M J, Braselmann, H, Fornander, T, Bartlett, J M S
Publicado 2007

Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients

por Aubele, M, Walch, A K, Ludyga, N, Braselmann, H, Atkinson, M J, Luber, B, Auer, G, Tapio, S, Cooke, T, Bartlett, J M S
Publicado 2008

MiR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasion

por Falkenberg, N, Anastasov, N, Rappl, K, Braselmann, H, Auer, G, Walch, A, Huber, M, Höfig, I, Schmitt, M, Höfler, H, Atkinson, M J, Aubele, M
Publicado 2013

In situ quantification of HER2–protein tyrosine kinase 6 (PTK6) protein–protein complexes in paraffin sections from breast cancer tissues

por Aubele, M, Spears, M, Ludyga, N, Braselmann, H, Feuchtinger, A, Taylor, K J, Lindner, K, Auer, G, Stering, K, Höfler, H, Schmitt, M, Bartlett, J M S
Publicado 2010

Somatic copy number changes in DPYD are associated with lower risk of recurrence in triple-negative breast cancers

por Gross, E, Meul, C, Raab, S, Propping, C, Avril, S, Aubele, M, Gkazepis, A, Schuster, T, Grebenchtchikov, N, Schmitt, M, Kiechle, M, Meijer, J, Vijzelaar, R, Meindl, A, van Kuilenburg, A B P
Publicado 2013